Total phenolic content, flavonoid content and antioxidant potential of Petasites hybridus and related species from Croatia and considerations regarding their pharmaceutical significance.

IF 2.1 4区 医学 Q3 PHARMACOLOGY & PHARMACY
Maja Friščić, Katarina Vilić, Sandra Jurić, Kroata Hazler Pilepić, Željan Maleš
{"title":"Total phenolic content, flavonoid content and antioxidant potential of <i>Petasites hybridus</i> and related species from Croatia and considerations regarding their pharmaceutical significance.","authors":"Maja Friščić, Katarina Vilić, Sandra Jurić, Kroata Hazler Pilepić, Željan Maleš","doi":"10.2478/acph-2024-0032","DOIUrl":null,"url":null,"abstract":"<p><p>Extracts obtained from common butterbur (<i>Petasites hybridus</i>), standardized to petasins, are existing pharmaceutical options for the treatment and/or prevention of allergic rhinitis (leaves) and migraine (rhizomes). In this study, the total phenolic content, flavonoid content, and antioxidant potential of ten samples of Croatian <i>Petasites</i> species (four <i>P. hybridus</i>, four <i>P. albus</i>, one <i>P. kabli kianus</i>, and one <i>P. paradoxus</i>) obtained by ultrasound-assisted extraction of leaves were compared. The total phenolic content (Folin-Ciocalteu assay) of methanolic leaf extracts ranged from 4.43 ± 0.09 to 10.76 ± 0.60 mg gallic acid equivalent g<sup>-1</sup> dry mass (mg GAE g<sup>-1</sup> DM) for <i>P. hybridus</i> and from 6.66 ± 0.43 to 19.92 ± 2.90 mg GAE g<sup>-1</sup> DM for <i>P. albus</i> samples, while those of <i>P. kablikianus</i> and <i>P. paradoxus</i> were equal to 7.56 ± 0.17 mg GAE g<sup>-1</sup> DM and 10.22 ± 0.46 mg GAE g<sup>-1</sup> DM, respectively. Flavonoid content (AlCl<sub>3</sub> assay) varied between 2.51 ± 0.10 and 4.03 ± 0.08 mg quercetin equivalent g<sup>-1</sup> dry mass (mg QE g<sup>-1</sup> DM) for <i>P. hybridus</i> and between 2.21 ± 0.09 and 5.22 ± 0.02 mg QE g<sup>-1</sup> DM for <i>P. albus</i> samples, while those of <i>P. kablikianus</i> and <i>P. paradoxus</i> were equal to 5.59 ± 0.05 mg QE g<sup>-1</sup> DM and 5.50 ± 0.09 mg QE g<sup>-1</sup> DM, respectively. Antioxidant potential was in high correlation with total phenolic content (<i>r</i> = 0.93, <i>p</i> < 0.001). Due to the expected contribution of plant polyphenols and flavonoids to the activity of butterbur extracts and their observed great variabilities, determining the content of these compounds may be of interest to the pharmaceutical industry.</p>","PeriodicalId":7034,"journal":{"name":"Acta Pharmaceutica","volume":" ","pages":""},"PeriodicalIF":2.1000,"publicationDate":"2024-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta Pharmaceutica","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2478/acph-2024-0032","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Extracts obtained from common butterbur (Petasites hybridus), standardized to petasins, are existing pharmaceutical options for the treatment and/or prevention of allergic rhinitis (leaves) and migraine (rhizomes). In this study, the total phenolic content, flavonoid content, and antioxidant potential of ten samples of Croatian Petasites species (four P. hybridus, four P. albus, one P. kabli kianus, and one P. paradoxus) obtained by ultrasound-assisted extraction of leaves were compared. The total phenolic content (Folin-Ciocalteu assay) of methanolic leaf extracts ranged from 4.43 ± 0.09 to 10.76 ± 0.60 mg gallic acid equivalent g-1 dry mass (mg GAE g-1 DM) for P. hybridus and from 6.66 ± 0.43 to 19.92 ± 2.90 mg GAE g-1 DM for P. albus samples, while those of P. kablikianus and P. paradoxus were equal to 7.56 ± 0.17 mg GAE g-1 DM and 10.22 ± 0.46 mg GAE g-1 DM, respectively. Flavonoid content (AlCl3 assay) varied between 2.51 ± 0.10 and 4.03 ± 0.08 mg quercetin equivalent g-1 dry mass (mg QE g-1 DM) for P. hybridus and between 2.21 ± 0.09 and 5.22 ± 0.02 mg QE g-1 DM for P. albus samples, while those of P. kablikianus and P. paradoxus were equal to 5.59 ± 0.05 mg QE g-1 DM and 5.50 ± 0.09 mg QE g-1 DM, respectively. Antioxidant potential was in high correlation with total phenolic content (r = 0.93, p < 0.001). Due to the expected contribution of plant polyphenols and flavonoids to the activity of butterbur extracts and their observed great variabilities, determining the content of these compounds may be of interest to the pharmaceutical industry.

克罗地亚杂交矮牵牛及相关物种的总酚含量、类黄酮含量和抗氧化潜力,以及对其制药意义的考虑。
从普通毛茛(Petasites hybridus)中提取的提取物(标准化为 petasins)是治疗和/或预防过敏性鼻炎(叶片)和偏头痛(根茎)的现有药物选择。本研究比较了通过超声辅助萃取叶片获得的十种克罗地亚矮牵牛样本(四种杂交矮牵牛、四种白矮牵牛、一种卡布利矮牵牛和一种矛盾矮牵牛)的总酚含量、类黄酮含量和抗氧化潜力。杂交种 P. 的甲醇叶提取物总酚含量(Folin-Ciocalteu 法)为 4.43 ± 0.09 至 10.76 ± 0.60 mg 没食子酸当量 g-1 干重(mg GAE g-1 DM),P. 的甲醇叶提取物总酚含量(Folin-Ciocalteu 法)为 6.66 ± 0.43 至 19.92 ± 2.90 mg GAE g-1 DM,而 P. kablikianus 和 P. paradoxus 的含量分别为 7.56 ± 0.17 mg GAE g-1 DM 和 10.22 ± 0.46 mg GAE g-1 DM。黄酮类化合物含量(AlCl3 检测法)的变化范围为:杂交种 P. 样品介于 2.51 ± 0.10 和 4.03 ± 0.08 毫克槲皮素当量 g-1 干重(mg QE g-1 DM)之间,白头翁 P. 样品介于 2.21 ± 0.09 和 5.22 ± 0.02 毫克 QE g-1 DM 之间,而卡布力翁 P. 样品和矛盾翁 P. 样品的黄酮类化合物含量分别为 5.59 ± 0.05 毫克 QE g-1 DM 和 5.50 ± 0.09 毫克 QE g-1 DM。抗氧化潜力与总酚含量高度相关(r = 0.93,p < 0.001)。由于植物多酚和类黄酮对毛茛提取物活性的预期贡献及其观察到的巨大差异,确定这些化合物的含量可能对制药业有意义。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Acta Pharmaceutica
Acta Pharmaceutica PHARMACOLOGY & PHARMACY-
CiteScore
5.20
自引率
3.60%
发文量
20
审稿时长
>12 weeks
期刊介绍: AP is an international, multidisciplinary journal devoted to pharmaceutical and allied sciences and contains articles predominantly on core biomedical and health subjects. The aim of AP is to increase the impact of pharmaceutical research in academia, industry and laboratories. With strong emphasis on quality and originality, AP publishes reports from the discovery of a drug up to clinical practice. Topics covered are: analytics, biochemistry, biopharmaceutics, biotechnology, cell biology, cell cultures, clinical pharmacy, drug design, drug delivery, drug disposition, drug stability, gene technology, medicine (including diagnostics and therapy), medicinal chemistry, metabolism, molecular modeling, pharmacology (clinical and animal), peptide and protein chemistry, pharmacognosy, pharmacoepidemiology, pharmacoeconomics, pharmacodynamics and pharmacokinetics, protein design, radiopharmaceuticals, and toxicology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信